Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Profit After Tax (2020 - 2025)

Historic Profit After Tax for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to -$9.8 million.

  • RxSight's Profit After Tax fell 5487.54% to -$9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$35.7 million, marking a year-over-year decrease of 1640.71%. This contributed to the annual value of -$27.5 million for FY2024, which is 4351.75% up from last year.
  • RxSight's Profit After Tax amounted to -$9.8 million in Q3 2025, which was down 5487.54% from -$11.8 million recorded in Q2 2025.
  • RxSight's 5-year Profit After Tax high stood at -$5.9 million for Q4 2024, and its period low was -$17.6 million during Q1 2022.
  • Its 5-year average for Profit After Tax is -$11.6 million, with a median of -$12.4 million in 2023.
  • As far as peak fluctuations go, RxSight's Profit After Tax tumbled by 15983.65% in 2021, and later soared by 5596.2% in 2024.
  • Over the past 5 years, RxSight's Profit After Tax (Quarter) stood at -$15.7 million in 2021, then grew by 0.79% to -$15.6 million in 2022, then soared by 41.21% to -$9.2 million in 2023, then surged by 35.29% to -$5.9 million in 2024, then crashed by 65.31% to -$9.8 million in 2025.
  • Its Profit After Tax was -$9.8 million in Q3 2025, compared to -$11.8 million in Q2 2025 and -$8.2 million in Q1 2025.